The rise of Sildenafil initially sparked a period of growth for major pharmaceutical companies, but recent changes present a uncertain scenario for investors. Off-patent alternatives are eroding profits, and continued https://ammarutpv679205.free-blogz.com/88746208/the-blue-pill-and-pharma-a-volatile-bet